Biohaven has suffered a few setbacks in recent months, including an FDA rejection and a missed $150 million benchmark payment ...
Prediction market apps are thriving in Trump's second term, with traders betting on migrant deportations to election outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback